Cancer Research SABCS  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 933-939, March 1, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farrell, C. L.
Right arrow Articles by Lacey, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farrell, C. L.
Right arrow Articles by Lacey, D. L.

Keratinocyte Growth Factor Protects Mice from Chemotherapy and Radiation-induced Gastrointestinal Injury and Mortality1

Catherine L. Farrell2, James V. Bready, Karen L. Rex, Jennifer N. Chen, Christopher R. DiPalma, K. Lane Whitcomb, Songmei Yin, David C. Hill, Bernadette Wiemann, Charlie O. Starnes, Andrew M. Havill, Zhao-N. Lu, Sharon L. Aukerman3, Glenn F. Pierce3, Arlen Thomason, Christopher S. Potten, Thomas R. Ulich and David L. Lacey

Amgen Center, Thousand Oaks, California 91320-1789 [C. L. F., J. V. B., K. L. R., J. N. C., C. R. D., K. L. W., S. Y., D. C. H., B. W., C. O. S., A. M. H., Z-N. L., S. L. A., G. F. P., A. T., T. R. U., D. L. L.], and Christine CRC Research Centre, Patterson Institute for Cancer Research, Manchester M20 9BX, United Kingdom [C. S. P.]

Keratinocyte growth factor (KGF) stimulates the proliferation and differentiation of epithelial cells including those of the gastrointestinal tract. Although chemotherapeutics and radiation exposure kill rapidly proliferating tumor cells, rapidly dividing normal cells of the host's gastrointestinal tract are also frequently damaged, leading to the clinical condition broadly termed "mucositis." In this report, recombinant human KGF used as a pretreatment in several mouse models of chemotherapy and/or radiation-induced gastrointestinal injury significantly improved mouse survival. Using multiple-dose 5-fluorouracil, methotrexate, and radiation in combination and total body radiation alone models, KGF increased survival by 55% or greater. In the models that used chemotherapy with or without radiation, KGF significantly ameliorated weight loss after injury and accelerated weight gain during recovery. The basis of these systemic benefits appears to be due in part to the trophic effects of the growth factor on the intestinal epithelium because KGF pretreatment caused an increase in measures of mucosal thickness (villus height and crypt depth) that persisted during the course of 5-fluorouracil chemotherapy. Treatment with KGF also afforded a 3.5-fold improvement in crypt survival in the small intestine, suggesting that KGF also has a direct effect on the crypt stem cells. These data indicate that KGF may be therapeutically useful to lessen the intestinal side effects of current cancer therapy regimens.

1 The work of C. S. P. was funded by the Cancer Research Campaign.

2 To whom requests for reprints should be addressed, at Amgen, Inc., 1840 DeHavilland Drive, Thousand Oaks, CA 91320-1789.

3 Present address: Prizm Pharmaceuticals, San Diego, CA 92121.

Received 7/29/97. Accepted 12/31/97.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
C. Zheng, A. P. Cotrim, A. N. Sunshine, T. Sugito, L. Liu, A. Sowers, J. B. Mitchell, and B. J. Baum
Prevention of Radiation-Induced Oral Mucositis after Adenoviral Vector-Mediated Transfer of the Keratinocyte Growth Factor cDNA to Mouse Submandibular Glands
Clin. Cancer Res., July 15, 2009; 15(14): 4641 - 4648.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. M. Stringer, R. J. Gibson, R. M. Logan, J. M. Bowen, A. S. J. Yeoh, J. Hamilton, and D. M. K. Keefe
Gastrointestinal Microflora and Mucins May Play a Critical Role in the Development of 5-Fluorouracil-Induced Gastrointestinal Mucositis
Experimental Biology and Medicine, April 1, 2009; 234(4): 430 - 441.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Zhao, K.-A. Kim, J. De Vera, S. Palencia, M. Wagle, and A. Abo
R-Spondin1 protects mice from chemotherapy or radiation-induced oral mucositis through the canonical Wnt/{beta}-catenin pathway
PNAS, February 17, 2009; 106(7): 2331 - 2336.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
B. King, E. Knopp, A. Galan, G. Nuovo, R. Tigelaar, and J. McNiff
Palifermin-Associated Papular Eruption
Arch Dermatol, February 1, 2009; 145(2): 179 - 182.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. L. Hensley, K. L. Hagerty, T. Kewalramani, D. M. Green, N. J. Meropol, T. H. Wasserman, G. I. Cohen, B. Emami, W. J. Gradishar, R. B. Mitchell, et al.
American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
J. Clin. Oncol., January 1, 2009; 27(1): 127 - 145.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
R. Brake, C. Starnes, J. Lu, D. Chen, S. Yang, R. Radinsky, and L. Borges
Effects of Palifermin on Antitumor Activity of Chemotherapeutic and Biological Agents in Human Head and Neck and Colorectal Carcinoma Xenograft Models
Mol. Cancer Res., August 1, 2008; 6(8): 1337 - 1346.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. Koria and S. T. Andreadis
KGF promotes integrin {alpha}5 expression through CCAAT/enhancer-binding protein-beta
Am J Physiol Cell Physiol, September 1, 2007; 293(3): C1020 - C1031.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
B. N. Gomperts, J. A. Belperio, M. C. Fishbein, M. P. Keane, M. D. Burdick, and R. M. Strieter
Keratinocyte Growth Factor Improves Repair in the Injured Tracheal Epithelium
Am. J. Respir. Cell Mol. Biol., July 1, 2007; 37(1): 48 - 56.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Seggewiss, K. Lore, F. J. Guenaga, S. Pittaluga, J. Mattapallil, C. K. Chow, R. A. Koup, K. Camphausen, M. C. Nason, M. Meier-Schellersheim, et al.
Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques.
Blood, July 1, 2007; 110(1): 441 - 449.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
N Blijlevens and S Sonis
Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis
Ann. Onc., May 1, 2007; 18(5): 817 - 826.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Min, A. Panoskaltsis-Mortari, M. Kuro-o, G. A. Hollander, B. R. Blazar, and K. I. Weinberg
Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging
Blood, March 15, 2007; 109(6): 2529 - 2537.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Braun, M. Krampert, E. Bodo, A. Kumin, C. Born-Berclaz, R. Paus, and S. Werner
Keratinocyte growth factor protects epidermis and hair follicles from cell death induced by UV irradiation, chemotherapeutic or cytotoxic agents
J. Cell Sci., December 1, 2006; 119(23): 4841 - 4849.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. J. Stiff, C. Emmanouilides, W. I. Bensinger, T. Gentile, B. Blazar, T. C. Shea, J. Lu, J. Isitt, A. Cesano, and R. Spielberger
Palifermin Reduces Patient-Reported Mouth and Throat Soreness and Improves Patient Functioning in the Hematopoietic Stem-Cell Transplantation Setting
J. Clin. Oncol., November 20, 2006; 24(33): 5186 - 5193.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
L. S. Rosen, E. Abdi, I. D. Davis, J. Gutheil, F. M. Schnell, J. Zalcberg, A. Cesano, U. Gayko, M.-G. Chen, and S. Clarke
Palifermin Reduces the Incidence of Oral Mucositis in Patients With Metastatic Colorectal Cancer Treated With Fluorouracil-Based Chemotherapy
J. Clin. Oncol., November 20, 2006; 24(33): 5194 - 5200.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. R. Blazar, D. J. Weisdorf, T. DeFor, A. Goldman, T. Braun, S. Silver, and J. L. M. Ferrara
Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT)
Blood, November 1, 2006; 108(9): 3216 - 3222.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. W. Finch and J. S. Rubin
Keratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors.
J Natl Cancer Inst, June 21, 2006; 98(12): 812 - 824.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. J. Geer, D. D. Swartz, and S. T. Andreadis
Biomimetic Delivery of Keratinocyte Growth Factor upon Cellular Demand for Accelerated Wound Healing in Vitro and in Vivo
Am. J. Pathol., December 1, 2005; 167(6): 1575 - 1586.
[Abstract] [Full Text] [PDF]


Home page
J Oncol Pharm PractHome page
M. L Radtke and J. M Kolesar
Palifermin (KepivanceTM) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support
Journal of Oncology Pharmacy Practice, September 1, 2005; 11(3): 121 - 125.
[Abstract] [PDF]


Home page
ScienceHome page
K.-A. Kim, M. Kakitani, J. Zhao, T. Oshima, T. Tang, M. Binnerts, Y. Liu, B. Boyle, E. Park, P. Emtage, et al.
Mitogenic Influence of Human R-Spondin1 on the Intestinal Epithelium
Science, August 19, 2005; 309(5738): 1256 - 1259.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Vidrich, J. M. Buzan, S. Barnes, B. K. Reuter, K. Skaar, C. Ilo, F. Cominelli, T. Pizarro, and S. M. Cohn
Altered Epithelial Cell Lineage Allocation and Global Expansion of the Crypt Epithelial Stem Cell Population Are Associated with Ileitis in SAMP1/YitFc Mice
Am. J. Pathol., April 1, 2005; 166(4): 1055 - 1067.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. Spielberger, P. Stiff, W. Bensinger, T. Gentile, D. Weisdorf, T. Kewalramani, T. Shea, S. Yanovich, K. Hansen, S. Noga, et al.
Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
N. Engl. J. Med., December 16, 2004; 351(25): 2590 - 2598.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. A. Garfunkel
Oral Mucositis -- The Search for a Solution
N. Engl. J. Med., December 16, 2004; 351(25): 2649 - 2651.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Zhao, L. Huang, N. Belmar, R. Buelow, and T. Fong
Oral RDP58 Allows CPT-11 Dose Intensification for Enhanced Tumor Response by Decreasing Gastrointestinal Toxicity
Clin. Cancer Res., April 15, 2004; 10(8): 2851 - 2859.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Yang, P. A. Antony, B. E. Wildhaber, and D. H. Teitelbaum
Intestinal Intraepithelial Lymphocyte {gamma}{delta}-T Cell-Derived Keratinocyte Growth Factor Modulates Epithelial Growth in the Mouse
J. Immunol., April 1, 2004; 172(7): 4151 - 4158.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. J. Egan, L. Eckmann, F. R. Greten, S. Chae, Z.-W. Li, G. M. Myhre, S. Robine, M. Karin, and M. F. Kagnoff
I{kappa}B-kinase{beta}-dependent NF-{kappa}B activation provides radioprotection to the intestinal epithelium
PNAS, February 24, 2004; 101(8): 2452 - 2457.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. O. Morvan, B. Baroukh, D. Ledoux, J.-P. Caruelle, D. Barritault, G. Godeau, and J.-L. Saffar
An Engineered Biopolymer Prevents Mucositis Induced by 5-Fluorouracil in Hamsters
Am. J. Pathol., February 1, 2004; 164(2): 739 - 746.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Alvarez, E. G. Fey, P. Valax, Z. Yim, J. D. Peterson, M. Mesri, M. Jeffers, M. Dindinger, N. Twomlow, A. Ghatpande, et al.
Preclinical Characterization of CG53135 (FGF-20) in Radiation and Concomitant Chemotherapy/Radiation-induced Oral Mucositis
Clin. Cancer Res., August 1, 2003; 9(9): 3454 - 3461.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
N. J. Meropol, R. A. Somer, J. Gutheil, R. J. Pelley, M. R. Modiano, E. K. Rowinsky, M. L. Rothenberg, S. W. Redding, C. M. Serdar, B. Yao, et al.
Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal Protectant
J. Clin. Oncol., April 15, 2003; 21(8): 1452 - 1458.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Fernandez-Estivariz, L. H. Gu, L. Gu, C. R. Jonas, T. M. Wallace, R. R. Pascal, K. L. Devaney, C. L. Farrell, D. P. Jones, D. K. Podolsky, et al.
Trefoil peptide expression and goblet cell number in rat intestine: effects of KGF and fasting-refeeding
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R564 - R573.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
N. Dainiak, J. K. Waselenko, J. O. Armitage, T. J. MacVittie, and A. M. Farese
The Hematologist and Radiation Casualties
Hematology, January 1, 2003; 2003(1): 473 - 496.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ruehl, R. Somasundaram, I. Schoenfelder, R. W. Farndale, C. G. Knight, M. Schmid, R. Ackermann, E. O. Riecken, M. Zeitz, and D. Schuppan
The Epithelial Mitogen Keratinocyte Growth Factor Binds to Collagens via the Consensus Sequence Glycine-Proline-Hydroxyproline
J. Biol. Chem., July 19, 2002; 277(30): 26872 - 26878.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Rossi, B. R. Blazar, C. L. Farrell, D. M. Danilenko, D. L. Lacey, K. I. Weinberg, W. Krenger, and G. A. Hollander
Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease
Blood, June 28, 2002; 100(2): 682 - 691.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Min, P. A. Taylor, A. Panoskaltsis-Mortari, B. Chung, D. M. Danilenko, C. Farrell, D. L. Lacey, B. R. Blazar, and K. I. Weinberg
Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation
Blood, May 29, 2002; 99(12): 4592 - 4600.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
F. R. Byrne, C. L. Farrell, R. Aranda, K. L. Rex, S. Scully, H. L. Brown, S. A. Flores, L. H. Gu, D. M. Danilenko, D. L. Lacey, et al.
rHuKGF ameliorates symptoms in DSS and CD4+CD45RBHi T cell transfer mouse models of inflammatory bowel disease
Am J Physiol Gastrointest Liver Physiol, April 1, 2002; 282(4): G690 - G701.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
D. Booth and C. S. Potten
Protection Against Mucosal Injury By Growth Factors and Cytokines
J Natl Cancer Inst Monographs, October 1, 2001; 2001(29): 16 - 20.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Bjerknes and H. Cheng
Modulation of specific intestinal epithelial progenitors by enteric neurons
PNAS, September 19, 2001; (2001) 211278098.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
C. S. Potten, J. A. O'Shea, C. L. Farrell, K. Rex, and C. Booth
The Effects of Repeated Doses of Keratinocyte Growth Factor on Cell Proliferation in the Cellular Hierarchy of the Crypts of the Murine Small Intestine
Cell Growth Differ., May 1, 2001; 12(5): 265 - 275.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. A. Welniak, A. R. Khaled, M. R. Anver, K. L. Komschlies, R. H. Wiltrout, S. Durum, F. R. Ruscetti, B. R. Blazar, and W. J. Murphy
Gastrointestinal Cells of IL-7 Receptor Null Mice Exhibit Increased Sensitivity to Irradiation
J. Immunol., March 1, 2001; 166(5): 2923 - 2928.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. P. Boushey, B. Yusta, and D. J. Drucker
Glucagon-like Peptide (GLP)-2 Reduces Chemotherapy-associated Mortality and Enhances Cell Survival in Cells Expressing a Transfected GLP-2 Receptor
Cancer Res., January 1, 2001; 61(2): 687 - 693.
[Abstract] [Full Text]


Home page
BloodHome page
A. Panoskaltsis-Mortari, P. A. Taylor, J. S. Rubin, A. Uren, L. A. Welniak, W. J. Murphy, C. L. Farrell, D. L. Lacey, and B. R. Blazar
Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury
Blood, December 15, 2000; 96(13): 4350 - 4356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Verburg, I. B. Renes, H. P. Meijer, J. A. J. M. Taminiau, H. A. Buller, A. W. C. Einerhand, and J. Dekker
Selective sparing of goblet cells and Paneth cells in the intestine of methotrexate-treated rats
Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G1037 - G1047.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. S. Esworthy, J. R. Mann, M. Sam, and F.-F. Chu
Low glutathione peroxidase activity in Gpx1 knockout mice protects jejunum crypts from gamma -irradiation damage
Am J Physiol Gastrointest Liver Physiol, August 1, 2000; 279(2): G426 - G436.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Panoskaltsis-Mortari, D. H. Ingbar, P. Jung, I. Y. Haddad, P. B. Bitterman, O. D. Wangensteen, C. L. Farrell, D. L. Lacey, and B. R. Blazar
KGF pretreatment decreases B7 and granzyme B expression and hastens repair in lungs of mice after allogeneic BMT
Am J Physiol Lung Cell Mol Physiol, May 1, 2000; 278(5): L988 - L999.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. R. Hill and J. L. M. Ferrara
The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation
Blood, May 1, 2000; 95(9): 2754 - 2759.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
P W Finch and A L Cheng
Analysis of the cellular basis of keratinocyte growth factor overexpression in inflammatory bowel disease
Gut, December 1, 1999; 45(6): 848 - 855.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. I. Krijanovski, G. R. Hill, K. R. Cooke, T. Teshima, J. M. Crawford, Y. S. Brinson, and J. L.M. Ferrara
Keratinocyte Growth Factor Separates Graft-Versus-Leukemia Effects From Graft-Versus-Host Disease
Blood, July 15, 1999; 94(2): 825 - 831.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Miceli, M. Hubert, G. Santiago, D.-L. Yao, T. A. Coleman, K. A. Huddleston, and K. Connolly
Efficacy of Keratinocyte Growth Factor-2 in Dextran Sulfate Sodium-Induced Murine Colitis
J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 464 - 471.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
C. R. Jonas, C. F. Estívariz, D. P. Jones, L. H. Gu, T. M. Wallace, E. E. Diaz, R. R. Pascal, G. A. Cotsonis, and T. R. Ziegler
Keratinocyte Growth Factor Enhances Glutathione Redox State in Rat Intestinal Mucosa during Nutritional Repletion
J. Nutr., July 1, 1999; 129(7): 1278 - 1284.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
P Gillis, U Savla, O. Volpert, B Jimenez, C. Waters, R. Panos, and N. Bouck
Keratinocyte growth factor induces angiogenesis and protects endothelial barrier function
J. Cell Sci., January 6, 1999; 112(12): 2049 - 2057.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
D. M. Danilenko
Preclinical and Early Clinical Development of Keratinocyte Growth Factor, an Epithelial- Specific Tissue Growth Factor
Toxicol Pathol, January 1, 1999; 27(1): 64 - 71.
[Abstract] [PDF]


Home page
BloodHome page
A. Panoskaltsis-Mortari, D. L. Lacey, D. A. Vallera, and B. R. Blazar
Keratinocyte Growth Factor Administered Before Conditioning Ameliorates Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation in Mice
Blood, November 15, 1998; 92(10): 3960 - 3967.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Guo, E. S. Yi, A. M. Havill, I. Sarosi, L. Whitcomb, S. Yin, S. C. Middleton, P. Piguet, and T. R. Ulich
Intravenous keratinocyte growth factor protects against experimental pulmonary injury
Am J Physiol Lung Cell Mol Physiol, October 1, 1998; 275(4): L800 - L805.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
C. F. Estivariz, C. R. Jonas, L. H. Gu, E. E. Diaz, T. M. Wallace, R. R. Pascal, C. L. Farrell, and T. R. Ziegler
Gut-Trophic Effects of Keratinocyte Growth Factor in Rat Small Intestine and Colon During Enteral Refeeding
JPEN J Parenter Enteral Nutr, September 1, 1998; 22(5): 259 - 267.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Bjerknes and H. Cheng
Modulation of specific intestinal epithelial progenitors by enteric neurons
PNAS, October 23, 2001; 98(22): 12497 - 12502.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
F. S. Huang, C. J. Kemp, J. L. Williams, C. R. Erwin, and B. W. Warner
Role of epidermal growth factor and its receptor in chemotherapy-induced intestinal injury
Am J Physiol Gastrointest Liver Physiol, March 1, 2002; 282(3): G432 - G442.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.